GSK Pharma reported strong Q1 consolidated revenue of ₹938.44 Cr and profit of ₹237.18 Cr.

Key management changes include Mr. Subesh Williams' resignation, Ms. Karine J F Natland's appointment as Non-Executive Director, and Mr. Bhushan Akshikar's re-appointment as MD for two years.